@article{3000407,
    title = "ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) 
POLLAR (Impact of Air POLLution on Asthma and Rhinitis)
GARD Demonstration project",
    author = "Bosnic-Anticevich, S. and Costa, E. and Menditto, E. and Lourenço, O. and Novellino, E. and Bialek, S. and Briedis, V. and Buonaiuto, R. and Chrystyn, H. and Cvetkovski, B. and Di Capua, S. and Kritikos, V. and Mair, A. and Orlando, V. and Paulino, E. and Salimäki, J. and Söderlund, R. and Tan, R. and Williams, D.M. and Wroczynski, P. and Agache, I. and Ansotegui, I.J. and Anto, J.M. and Bedbrook, A. and Bachert, C. and Bewick, M. and Bindslev-Jensen, C. and Brozek, J.L. and Canonica, G.W. and Cardona, V. and Carr, W. and Casale, T.B. and Chavannes, N.H. and Correia de Sousa, J. and Cruz, A.A. and Czarlewski, W. and De Carlo, G. and Demoly, P. and Devillier, P. and Dykewicz, M.S. and Gaga, M. and El-Gamal, Y. and Fonseca, J. and Fokkens, W.J. and Guzmán, M.A. and Haahtela, T. and Hellings, P.W. and Illario, M. and Ivancevich, J.C. and Just, J. and Kaidashev, I. and Khaitov, M. and Khaltaev, N. and Keil, T. and Klimek, L. and Kowalski, M.L. and Kuna, P. and Kvedariene, V. and Larenas-Linnemann, D.E. and Laune, D. and Le, L.T.T. and Lodrup Carlsen, K.C. and Mahboub, B. and Maier, D. and Malva, J. and Manning, P.J. and Morais-Almeida, M. and Mösges, R. and Mullol, J. and Münter, L. and Murray, R. and Naclerio, R. and Namazova-Baranova, L. and Nekam, K. and Nyembue, T.D. and Okubo, K. and O'Hehir, R.E. and Ohta, K. and Okamoto, Y. and Onorato, G.L. and Palkonen, S. and Panzner, P. and Papadopoulos, N.G. and Park, H.-S. and Pawankar, R. and Pfaar, O. and Phillips, J. and Plavec, D. and Popov, T.A. and Potter, P.C. and Prokopakis, E.P. and Roller-Wirnsberger, R.E. and Rottem, M. and Ryan, D. and Samolinski, B. and Sanchez-Borges, M. and Schunemann, H.J. and Sheikh, A. and Sisul, J.C. and Somekh, D. and Stellato, C. and To, T. and Todo-Bom, A.M. and Tomazic, P.V. and Toppila-Salmi, S. and Valero, A. and Valiulis, A. and Valovirta, E. and Ventura, M.T. and Wagenmann, M. and Wallace, D. and Waserman, S. and Wickman, M. and Yiallouros, P.K. and Yorgancioglu, A. and Yusuf, O.M. and Zar, H.J. and Zernotti, M.E. and Zhang, L. and Zidarn, M. and Zuberbier, T. and Bousquet, J.",
    journal = "Allergy: European Journal of Allergy and Clinical Immunology",
    year = "2019",
    volume = "74",
    number = "7",
    pages = "1219-1236",
    publisher = "Wiley-Blackwell Publishing Ltd",
    doi = "10.1111/all.13701",
    keywords = "antihistaminic agent;  cholinergic receptor blocking agent;  chromone derivative;  corticosteroid;  decongestive agent;  non prescription drug;  steroid, allergic rhinitis;  asthma;  clinical decision support system;  disease classification;  human;  immunotherapy;  multiple chronic conditions;  patient referral;  pharmacist;  pharmacy (shop);  priority journal;  Review;  rhinitis;  allergic rhinitis;  clinical pathway;  community care;  disease management;  health survey;  immunology;  medication compliance;  professional standard;  symptom assessment;  telemedicine, Community Health Services;  Critical Pathways;  Decision Support Systems, Clinical;  Disease Management;  Humans;  Medication Adherence;  Pharmacies;  Pharmacists;  Professional Role;  Public Health Surveillance;  Rhinitis, Allergic;  Symptom Assessment;  Telemedicine",
    abstract = "Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care. © 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd."
}